Cosmo Pharmaceuticals Statistics

Total Valuation

LON:0RGI has a market cap or net worth of GBP 831.64 million. The enterprise value is 716.91 million.

Market Cap	831.64M
Enterprise Value	716.91M

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	16.02M
Shares Outstanding	n/a
Shares Change (YoY)	+1.94%
Shares Change (QoQ)	+3.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.52M

Valuation Ratios

The trailing PE ratio is 7.55 and the forward PE ratio is 19.13.

PE Ratio	7.55
Forward PE	19.13
PS Ratio	3.77
PB Ratio	1.99
P/TBV Ratio	3.22
P/FCF Ratio	6.37
P/OCF Ratio	6.19
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.20, with an EV/FCF ratio of 5.49.

EV / Earnings	6.51
EV / Sales	3.14
EV / EBITDA	5.20
EV / EBIT	5.62
EV / FCF	5.49

Financial Position

The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.00.

Current Ratio	4.19
Quick Ratio	3.39
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	2,809.12

Financial Efficiency

Return on equity (ROE) is 29.31% and return on invested capital (ROIC) is 20.39%.

Return on Equity (ROE)	29.31%
Return on Assets (ROA)	15.87%
Return on Invested Capital (ROIC)	20.39%
Return on Capital Employed (ROCE)	24.88%
Revenue Per Employee	685,173
Profits Per Employee	342,181
Employee Count	322
Asset Turnover	0.45
Inventory Turnover	3.27

Taxes

In the past 12 months, LON:0RGI has paid 16.68 million in taxes.

Income Tax	16.68M
Effective Tax Rate	13.16%

Stock Price Statistics

The stock price has decreased by -18.61% in the last 52 weeks. The beta is 1.30, so LON:0RGI's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-18.61%
50-Day Moving Average	53.25
200-Day Moving Average	62.61
Relative Strength Index (RSI)	54.13
Average Volume (20 Days)	2,576

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RGI had revenue of GBP 220.63 million and earned 110.18 million in profits. Earnings per share was 6.71.

Revenue	220.63M
Gross Profit	183.12M
Operating Income	123.12M
Pretax Income	126.83M
Net Income	110.18M
EBITDA	132.70M
EBIT	123.12M
Earnings Per Share (EPS)	6.71

Full Income Statement

Balance Sheet

The company has 118.23 million in cash and 1.82 million in debt, giving a net cash position of 116.41 million.

Cash & Cash Equivalents	118.23M
Total Debt	1.82M
Net Cash	116.41M
Net Cash Per Share	n/a
Equity (Book Value)	417.69M
Book Value Per Share	25.73
Working Capital	127.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 134.31 million and capital expenditures -3.76 million, giving a free cash flow of 130.54 million.

Operating Cash Flow	134.31M
Capital Expenditures	-3.76M
Free Cash Flow	130.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 83.00%, with operating and profit margins of 55.81% and 49.94%.

Gross Margin	83.00%
Operating Margin	55.81%
Pretax Margin	57.49%
Profit Margin	49.94%
EBITDA Margin	60.15%
EBIT Margin	55.81%
FCF Margin	59.17%

Dividends & Yields

This stock pays an annual dividend of 1.73, which amounts to a dividend yield of 3.02%.

Dividend Per Share	1.73
Dividend Yield	3.02%
Dividend Growth (YoY)	2.89%
Years of Dividend Growth	2
Payout Ratio	24.09%
Buyback Yield	-1.94%
Shareholder Yield	1.08%
Earnings Yield	13.25%
FCF Yield	15.70%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RGI has an Altman Z-Score of 7.21 and a Piotroski F-Score of 8.

Altman Z-Score	7.21
Piotroski F-Score	8